Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy

High Blood Press Cardiovasc Prev. 2018 Sep;25(3):327-341. doi: 10.1007/s40292-018-0278-8. Epub 2018 Sep 20.

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death, disability and hospitalization in Italy. Primary prevention strategies are able to prevent clinically evident CVDs, mostly by early identifying asymptomatic, otherwise healthy individuals at risk of developing CVDs. A more modern approach recommended for effective CVD prevention is based on "4P", that is: Predictive, Preventive, Personalized and Participative. This executive document reflects the key points of a consensus paper on CV prevention in Italy, realized though the contribution of different Italian Scientific Societies and the National Research Council, and coordinated by the Italian Society of Cardiovascular Prevention (SIPREC), published in 2018. The need for such document relies on the difficulty to apply "sic et simpliciter" European guidelines, to which this document is largely inspired, to national, regional and local realities, in this Mediterranean country, namely Italy. Indeed, our Country has specific features in terms of demography, socio-cultural habits, distribution and prevalence of risk factors, organization, policy and access to National Health Service compared to other European countries.

Keywords: Cardiovascular mortality; Cardiovascular prevention; Cardiovascular risk factors; Diabetes; Dyslipidaemia; Hypertension; Obesity; Smoking; Vaccination.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Anticholesteremic Agents / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular Diseases / prevention & control*
  • Child
  • Diet, Healthy
  • Exercise
  • Female
  • Healthy Lifestyle*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use
  • Predictive Value of Tests
  • Prevalence
  • Primary Prevention / methods*
  • Primary Prevention / standards
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Risk Reduction Behavior
  • Sex Factors
  • Smoking Cessation
  • Vaccination
  • Weight Loss
  • Young Adult

Substances

  • Anticholesteremic Agents
  • Antihypertensive Agents
  • Hypoglycemic Agents
  • Platelet Aggregation Inhibitors